Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nutriband Inc. - Common Stock
(NQ:
NTRB
)
4.660
+0.130 (+2.87%)
Streaming Delayed Price
Updated: 9:43 AM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,155
Open
4.570
Bid (Size)
4.610 (100)
Ask (Size)
4.760 (200)
Prev. Close
4.530
Today's Range
4.570 - 4.681
52wk Range
3.722 - 11.78
Shares Outstanding
6,356,270
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Signs LOI to Explore Quantum-AI Technology Collaboration
December 19, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Responds to Fentanyl WMD Executive Order, Highlights AVERSA(TM) FENTANYL Development
December 18, 2025
Via
Investor Brand Network
Topics
Government
Performance
YTD
+2.4%
+2.4%
1 Month
-0.4%
-0.4%
3 Month
-33.8%
-33.8%
6 Month
-40.3%
-40.3%
1 Year
+17.1%
+17.1%
More News
Read More
Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
December 18, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
December 18, 2025
From
Nutriband Inc.
Via
GlobeNewswire
NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Chairman Presentation at NobleCon21
November 24, 2025
Via
Investor Brand Network
REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
October 28, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission
October 28, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 28, 2025
Via
Benzinga
Nutriband Inc. (NASDAQ:NTRB) Targets the Opioid Safety Gap in a Multi-Billion-Dollar Market
October 28, 2025
Via
AB Newswire
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
October 28, 2025
From
Nutriband Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Founder Gareth Sheridan Returns as CEO to Lead Final Development Phase of AVERSA Fentanyl
October 27, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Co-Founder Gareth Sheridan Returns as CEO
October 27, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Featured in Channelchek Report Highlighting AVERSA Fentanyl Progress
October 24, 2025
Via
Investor Brand Network
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Partners with Brand Institute to Develop Global Brand Identity for AVERSA FENTANYL
October 10, 2025
Via
Investor Brand Network
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
October 10, 2025
From
Nutriband Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Files Provisional Patent to Strengthen Protection of AVERSA(TM) Abuse-Deterrent Technology
October 09, 2025
Via
Investor Brand Network
Topics
Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
October 08, 2025
Via
Investor Brand Network
Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology
October 08, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference
October 08, 2025
From
Nutriband Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at MicroCap Rodeo Conference
September 25, 2025
Via
Investor Brand Network
11 Company Presentations Today at The MicroCap Rodeo Conference
September 25, 2025
Via
ACCESS Newswire
Nutriband Inc. to Present at the MicroCap Rodeo Conference
September 24, 2025
From
Nutriband Inc.
Via
GlobeNewswire
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Eyes Clear Development Pathway for AVERSA(TM) Technology
September 19, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Reports 51% Revenue Growth, Strong Cash Position to Advance AVERSA Fentanyl
September 10, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB): When Market Confidence Validates Scientific Innovation
September 10, 2025
Via
Investor Brand Network
Frequently Asked Questions
Is Nutriband Inc. - Common Stock publicly traded?
Yes, Nutriband Inc. - Common Stock is publicly traded.
What exchange does Nutriband Inc. - Common Stock trade on?
Nutriband Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nutriband Inc. - Common Stock?
The ticker symbol for Nutriband Inc. - Common Stock is NTRB on the Nasdaq Stock Market
What is the current price of Nutriband Inc. - Common Stock?
The current price of Nutriband Inc. - Common Stock is 4.660
When was Nutriband Inc. - Common Stock last traded?
The last trade of Nutriband Inc. - Common Stock was at 12/24/25 09:43 AM ET
What is the market capitalization of Nutriband Inc. - Common Stock?
The market capitalization of Nutriband Inc. - Common Stock is 29.62M
How many shares of Nutriband Inc. - Common Stock are outstanding?
Nutriband Inc. - Common Stock has 30M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.